EMEA seeks opinions
The European Agency for the Evaluation of Medicinal Products (EMEA) has asked for comments from the pharmaceutical industry on its draft regulations covering the manufacture or the import of medicines that are still under investigation. The regulations would insist that appli- cations for author- isation should include information on qualified persons involved in the project and the site where manu- facturing and importation is to take place.